Singapore markets open in 6 hours 22 minutes
Straits Times Index
3,303.19 +10.26 (+0.31%) S&P 500
5,169.10 +41.31 (+0.81%) Dow
38,838.03 +162.35 (+0.42%) Nasdaq
16,297.79 +141.46 (+0.88%) Bitcoin USD
63,230.01 -669.46 (-1.05%) CMC Crypto 200
1,361.90 +49.27 (+3.75%)
PRTA May 2024 30.000 call
OPR - OPR Delayed price. Currency in USD
Add to watchlist
As of 12:58PM EDT. Market open.
| Previous close | 0.0500 |
| Open | 0.1500 |
| Bid | 0.1000 |
| Ask | 0.2000 |
| Strike | 30.00 |
| Expiry date | 2024-05-17 |
| Day's range | 0.1000 - 0.1500 |
| Contract range | N/A |
| Volume | |
| Open interest | 63 |
Business WireProthena to Report First Quarter 2024 Financial Results on May 8
DUBLIN, Ireland, May 01, 2024--Prothena announced that it will report first quarter 2024 financial results on Wednesday, May 8, 2024, after the close of the U.S. financial markets.
ZacksEarnings Preview: Prothena (PRTA) Q1 Earnings Expected to Decline
Prothena (PRTA) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Business WireProthena Announces Review on Birtamimab Mechanism of Action and Pharmacological Characteristics Published in Leukemia & Lymphoma
DUBLIN, April 15, 2024--Prothena today announced a publication related to the mechanism of action, pharmacological characteristics, and clinical utility of birtamimab.
© 2024 Yahoo. All rights reserved.